Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.280
+0.070 (5.79%)
Apr 29, 2026, 9:54 AM EDT - Market open
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $13.00 million as of April 29, 2026. Its market cap has increased by 28.12% in one year.
Market Cap
13.00M
Enterprise Value
8.47M
1-Year Change
28.12%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $13.00M, a decrease of -96.82%. That is a compound annual growth rate of -23.68%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 13.66M |
| Jupiter Neurosciences | 13.36M |
| Intensity Therapeutics | 13.13M |
| Cyclerion Therapeutics | 12.85M |
| Kairos Pharma | 12.63M |
| BioCardia | 12.47M |
| Lunai Bioworks | 12.32M |
| CDT Equity | 11.95M |